Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA fixes retail...

    NPPA fixes retail prices of 30 formulations, including Insulin, Metoprolol ER; check out details

    Written by Ruby Khatun Khatun Published On 2018-02-10T16:11:32+05:30  |  Updated On 10 Feb 2018 4:11 PM IST
    NPPA fixes retail prices of 30 formulations, including Insulin, Metoprolol ER; check out details

    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has fixed the retail prices of 30 formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).


    The notice states that in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table hereinbelow as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;


    Following are the details






































































































































































































































































    Sl.

    No.
    Name of the
    Formulation /Brand Name
    StrengthUnitManufacturer & Marketing Company Retail Price (Rs.)
    (1) (2)(3) (4)(5)(6)
    1.Paracetamol + Dicyclomine Tablet
    (Pacimol Spas)
    Each Uncoated tablet contains:
    Paracetamol IP 500mg,
    Dicyclomine Hydrochloride IP 20 mg
    1 TabletM/s Akums Drugs and
    Pharmaceutical Ltd. / M/s IPCA Laboratories Ltd.
    1.64
    2.Amoxicilin Potasium
    Clavulanate Tablet
    (Clavam Forte DT)
    Each uncoated dispersible tablet containing:
    Amoxicilin Trihydrate IP eq. to Amoxicilin 400mg, Potasium Clavulanate diluted IP eq. To Clavulanic acid 57 mg
    1 TabletM/s Alkem HealthscienceA
    unit of Alkem
    Laboratories/M/s Alkem labortories Ltd.
    16.35
    3.Telmisartan +
    Chlorthalidone Tablet
    (Tigatel CH40)
    Each film coated Tablet contains:
    Telmisartan IP 40mg,
    Chlorthalidone IP 12.5mg
    1 TabletM/s Sun Pharma
    Laboratories Limited
    7.64
    4.Cilnidipine +
    Telmisartan tablet
    (Telvacil 80mg)
    Each Tablet contains:
    Cilnidipine 10mg ,
    Telmisartan IP 80mg
    1 TabletM/Pure and Cure
    Healthcare Pvt. Ltd. / M/s
    Aristo Pharmaceuticals
    Pvt. Ltd.
    10.54
    5.Metoprolol ER TabletEach film coated extended release
    Tablet contains:
    Metoprolol Succinate IP 71.25mg eq. to
    Metoprolol Tartrate 75mg.
    1 TabletM/s Intas
    Pharmaceuticals Limited
    8.39
    6.Paracetamol +
    Caffeine Tablate
    (Pacimol Active)
    Each film coated Tablet contains:
    Paracetamol IP 650mg,
    Caffeine Anhydrous IP 50mg
    1 TabletM/s Ipca Laboratories
    Limited
    1.88
    7.Doxycyclilne + Lactic
    Acid Bacillus capsules
    Each hard Gelatin capsule contains:
    Doxycycline Hyclate eq. to Doxycycline
    100mg, Lactic Acid Bacillus 5 Billion
    Spores
    1 CapsuleM/s Mascot Health Series
    Pvt. Ltd. / M/s Zydus
    Healthcare Limited.
    5.56
    8.Doxycyclilne + Lactic
    Acid Bacillus capsules
    Each hard Gelatin capsule contains:
    Doxycycline Hyclate eq. to Doxycycline
    (Pellets) 100mg, Lactic Acid Bacillus
    (enteric coated Pellets) 5 Billion
    Spores
    1 CapsuleM/s Bennet
    Pharmaceuticals Ltd.
    5.56
    9.Cilnidipine +
    Telmisartan Tablet
    Each filmcoated tablet contains:
    Cilnidipine 10mg,
    Telmisartan IP 40mg
    1 TabletM/s Safteb Life Science /
    M/s Lupin Limited
    7.11
    10.Cilnidipine +
    Telmisartan Tablet
    Each filmcoated tablet contains:
    Cilnidipine 10mg,
    Telmisartan IP 40mg
    1 TabletM/s Akums Drugs &
    Pharmaceuticals Ltd. /
    M/s Aristo
    Pharmaceuticals Pvt. Ltd.
    7.11
    11.Levetiracetam TableEach film coated tablet contains:
    Levetiracetam IP 1000mg
    1 TabletM/s Mascot Health Series
    Pvt. Ltd. / M/s Zydus
    Healthcare Limited
    23.37
    12.Levetiracetam TableEach film coated tablet contains:
    Levetiracetam IP 1000mg
    1 TabletM/s Akums Drugs &
    Pharmaceuticals Ltd. /
    M/s Emcure
    Pharmaceuticals Limited
    23.37
    13.Phenylephrine +
    Chlorpheniramine
    Syrup
    Each 5 ml Contains:
    Phenylephrine Hydrochloride IP 5mg,
    Chlorpheniramine Maleate IP 2mg
    1 MLM/s Akums Drugs &
    Pharmaceuticals Ltd. /
    M/s Lifestar Pharma Pvt.
    Ltd.
    0.75
    14.Sumatriptan +
    Naproxen Tablet
    (NAXCOM)
    Each uncoated bilayer tablet contains:
    Sumatriptan Succinate IP eq. to
    Sumatriptan 85mg,
    Naproxen Sodium USP 500mg
    1 TabletM/Sun Pharma
    Laboratories Limited.
    30.82
    15.Cilnidipine +
    Telmisartan +
    Chlorthalidone Tablet
    Each film coated tablet contains:
    Cilnidipine 10mg,
    Telmisartan IP 40mg, Chlorthalidone
    IP 6.25mg
    1 TabletM/s Synokem
    Pharmaceuticals Ltd. /
    M/s Mankind Pharma
    Limited
    9.79
    16.Telmisartan +
    Amlodipine +
    Chlorthalidone Tablet
    (Telpres Trio)
    Each film coated tablet contains:
    Telmisartan IP 40mg,
    Amlodipine Besylate IP eq. to
    Amlodipine 5mg, Chlorthalidone IP
    12.5mg
    1 TabletM/s Akums Drugs &
    Pharmaceuticals Ltd. /
    M/s Abbott India Limited
    8.75
    17.Telmisartan +
    Amlodipine +
    Chlorthalidone Tablet
    (Tigatel ACH 40)
    Each film coated tablet contains:
    Telmisartan IP 40mg,
    Amlodipine Besylate IP eq. to
    Amlodipine 5mg, Chlorthalidone IP
    12.5mg
    1 TabletM/s Sun Pharma
    Laboratories Limited
    8.75
    18.Telmisartan +
    Amlodipine +
    Chlorthalidone Tablet
    (Tigatel ACH 80)
    Each uncoated tablet contains:
    Telmisartan IP 80mg, Amlodipine
    Besylate IP Eq. to Amlodipine 5mg &
    Chlorthalidone IP 12.5mg
    1 TabletM/Sun Pharma
    Laboratories Ltd.
    14.00
    19.Human Insulin
    Injection
    Each ml contains:
    Insulin Human (30 Percent as soluble Insulin Injection and 70 percent as Isophane Insulin Injection)(Human
    Insulin rDNA origin) IP 100 IU, MetaCreesol
    (as preservative) USP –0.16percent w/v, Phenol (as
    preservative) IP 0.065 percent w/v, water for Injection
    1 MLM/s MJ Biopharma Pvt.
    Ltd. / M/s Koye
    Pharmaceuticals Pvt. Ltd.
    63.66
    20.Human Insulin
    Injection
    Each ml contains:
    Insulin Human (50 Percent as soluble Insulin Injection and 50 percent as Isophane Insulin Injection)(Human
    Insulin rDNA origin) IP 100IU, MetaCresol
    (as preservative) USP – 0.16 percent w/v, Phenol (as preservative)
    IP 0.065 percent w/v, water for
    Injection
    1 MLM/s MJ Biopharma Pvt.
    Ltd. / M/s Koye
    Pharmaceuticals Pvt. Ltd.
    63.66
    21.Human Insulin
    Injection
    Each ml contains:
    Human Insulin (Human Insulin rDNA origin) IP 100IU, Meta-Cresol (as preservative) USP – 0.025 percent
    w/v, water for Injection
    1 MLM/s MJ Biopharma Pvt.
    Ltd. / M/s Koye
    Pharmaceuticals Pvt. Ltd.
    63.66
    22.Docetaxel +
    Polysorbate 80 +
    Ethanol + Citric Acid Monohydrate Injection (Docetaxel IP
    120mg/3ml)
    Each ml of concentrate contains:
    Docetaxel (as anhydrous) 40mg,
    Polysorbate 80 – 566mg,
    Ethanol Anhydrous 326mg,
    Citric Acid Monohydrate 2mg (for PH
    adjustment), water for injection
    Each Pack
    (120mg/3
    ml)
    M/s Venus Remedies Ltd.
    / M/s Cadila Healthcare
    Ltd.
    10280.34
    23.Escitalopram +
    Clonazepam Tablet
    (Szetalo Plus 5)
    Each film coated tablet contains:
    Escitalopram Oxalate IP eq. to
    Escitalopram 5mg, Clonazepam IP
    0.5mg
    1 TabletM/s Accent Pharma / M/s
    Abbott Healthcare
    Limited.
    3.83
    24.Telmisartan +
    Amlodipine Tablet
    (Telmiduce AM)
    Each uncoated tablet contains:
    Telmisartan IP 40mg, Amlodipine
    Besylate IP eq. to Amlodipine 5mg
    1 TabletM/s Macleods
    Pharmaceuticals Ltd.
    4.30
    25.Telmisartan +
    Hydrocholrothiazide
    Tablet
    (Telmiduce H 40)
    Each uncoated tablet contains:
    Telmisartan USP 40mg,
    Hydrocholrothiazide USP 12.50mg
    1 TabletM/s Macleods
    Pharmaceuticals Ltd.
    4.15
    26.Rosuvastatin + Aspirin
    + Clopidogrel Capsule
    (Rozucor Gold 10)
    Each Hard Gelatine Capsule contains:
    Rosuvastatin Calcium IP eq. to
    Rosuvastation 10mg (As pellets),
    Aspirin IP 75mg (As Gastro - resistant
    pellets),
    Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (As pellets)
    1 CapsuleM/s Synokem
    Pharmaceuticals Limited /
    M/s Torrent
    Pharmaceuticals Limited
    9.97
    27.Rosuvastatin + Aspirin
    + Clopidogrel Capsule
    (Rozucor Gold 20)
    Each Hard Gelatine Capsule contains:
    Rosuvastatin Calcium IP eq. to
    Rosuvastation 20mg (As pellets),
    Aspirin IP 75mg (As Gastro - resistant
    pellets),
    Clopidogrel Bisulphate IP eq. to
    Clopidogrel 75mg (As pellets)
    1 CapsuleM/s Synokem
    Pharmaceuticals Limited /
    M/s Torrent
    Pharmaceuticals Limited
    18.00
    28.Amoxycillin +
    Clavulante Suspension
    Each combipack contains: (a) One bottle of Amoxycillin &
    Potassium Clavunate Oral Suspension
    L.P. Each 5ml of reconstituted suspension
    contains: Amoxycillin Trihydrate IP eq. to
    Amoxycillin 400mg, Potassium
    Clavulante Diluted IP eq. to Clavulnic
    Acid 57mg
    1 MLM/s Twenty First Century
    Pharmaceuticals Pvt. Ltd./ M/s Glenmark
    Pharmaceuticals Ltd.
    2.91
    29.Paracetamol +
    Mafenamic Suspension
    (Pacimol MF 125)
    Each 5ml contains:
    Paracetamol IP 125mg,
    Mafenamic acid IP 50mg Flavoured
    Syrup base
    1 MLM/s Tirupati Medicare
    Limited / M/s IPCA Laboratories Pvt. Ltd.
    0.48
    30.Etoricoxib + Paracetamol Tablet
    (Etomax P)
    Each film coated tablet contains:
    Etoricoxib IP 60mg, Paracetamol IP
    325mg
    1 TabletM/s Ravenbhel Healthcare
    (P) Limited / M/s IPCA
    Laboratories Pvt. Ltd.
    5.14

    The manufacturers of above said scheduled formulations shall furnish the quarterly return to the NPPA, in respect of production/import and sale of scheduled formulations in Form - III of Schedule - II of the DPCO, 2013 through IPDMS.


    Any manufacturer intending to discontinue production of said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form -IV of Schedule - II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

    The manufacturers not complying with the ceiling price and notes specified shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.

    Consequent to the issue of ceiling prices of such formulations as specified, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.


    Medical Dialogues had earlier reported that NPPA had fixed the retail Prices of 5 formulations under DPCO 2013 exclusive of goods and services tax (GST) including those used for the treatment of hypertension, asthma and heart failure.


    Read also: NPPA fixes retail price of 5 formulations

    Department of PharmaceuticalsDrugs Prices Control OrderfixesformulationsGoods and Services TaxGovernment of IndiaGSTMinistry of Chemicals and FertilizersNational Pharmaceutical Pricing AuthorityNPPARetail Prices

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok